`In Reply to Office Action mailed 11/06/2015
`
`Amendments to the Claims:
`
`This listing of claims will replace all prior versions, and listing, of claims in the
`
`application.
`
`Listing of Claims:
`
`l.-l4.
`
`(Canceled)
`
`15.
`
`(Currently Amended) An analysis device, comprising:
`
`a microchannel structure rotatable about a rotation axis of the analysis device, the
`
`microchannel structure including a passage and a measuring cell; and
`
`an analysis reagent carried in the passage of the microchannel structure, the analysis
`
`reagent being in a solid and dry state, the analysis reagent comprising a combination of
`
`a polyanionic compound and a bivalent cationic compound, and one substance or one
`
`compound of the substance as an additive,
`
`wherein the substance is at least one selected from the group consisting of:
`
`succinic acid,
`
`gluconic acid,
`
`We:
`
`valine,
`
`histidine, and
`
`maltitol.
`
`l6.
`
`(Withdrawn-currently amended) An analysis device, comprising:
`
`a microchannel structure rotatable about a rotation axis of the analysis device, the
`
`microchannel structure including a passage and a measuring cell;
`
`an analysis reagent carried in the passage of the microchannel structure, the analysis
`
`reagent being in a solid and dry state, the analysis reagent comprising a combination of
`
`a polyanionic compound and a bivalent cationic compound, and one substance or one
`
`compound of the substance as an additive,
`
`wherein the substance is at least one selected from the group consisting of:
`
`dicarboxylic acid,
`
`
`
`S/N: 14/479,936
`In Reply to Office Action mailed 11/06/2015
`
`gluconic acid,
`
`alanine;
`
`glye'met
`
`valine,
`
`histidine,
`
`taurine,
`
`a sugar alcohol,
`
`xylose that is a monosaccharide,
`
`a disaccharide, and
`
`a trisaccharide.
`
`17.
`
`(Previously Presented) The analysis device according to claim 15, comprising:
`
`a reserving cavity that receives a fixed quantity of diluted plasma serving as a liquid
`
`sample;
`
`an operation cavity that is formed next to the reserving cavity in a circumferential
`
`direction, is connected to the reserving cavity via a connecting section enabling application
`
`of a capillary force, and contains a reagent for analyzing highdensity lipoprotein cholesterol;
`
`a separating cavity that is formed outside the operation cavity and is connected to the
`
`operation cavity via a connecting passage serving as a clearance configured to apply a
`
`capillary force;
`
`a measuring passage that is adjacent to the separating cavity in the circumferential
`
`direction and is connected to the separating cavity via a connecting passage configured to
`
`apply a capillary force;
`
`a measuring cell formed outside the measuring passage; and
`
`a capillary area that is formed inside the measuring cell and contains an enzyme
`
`reagent and a mediator,
`
`wherein a reaction solution having reacted in the capillary area is transferred to an
`
`outer periphery of the measuring cell by increasing the centrifugal force, and then the
`
`reaction solution retained on the outer periphery of the measuring cell is accessed to measure
`
`HDL of the liquid sample.
`
`
`
`S/N: 14/479,936
`In Reply to Office Action mailed 11/06/2015
`
`18 .
`
`(Previously Presented) The analysis device according to claim 17, wherein the
`
`operation cavity comprises a reagent carrying section configured to carry the reagent for
`
`analyzing high-density lipoprotein
`
`cholesterol, the reagent carrying section protruding from the operation cavity so as to have a
`
`clearance smaller than a clearance of the operation cavity.
`
`19.
`
`(Previously Presented) The analysis device according to claim 17, further comprising
`
`an agitating rib extended in a radial direction in the operation cavity, the agitating rib being
`
`lower in height than an external wall of the operation cavity.
`
`20.
`
`(New) The analysis device according to claim 15, wherein the substance is at least
`
`one selected from the group consisting of:
`
`succinate at a concentration of at least 5 mg/ml,
`
`gluconate at a concentration of at least 5 mg/ml,
`
`valine at a concentration of at least 5 mg/ml,
`
`histidine at a concentration of at least 5 mg/ml,
`
`histidine at a concentration of at least 5 mg/ml, and
`
`maltitol at a concentration of 1 mg/ml to 10 mg/ml.
`
`21.
`
`(New) The analysis device according to claim 15, wherein the substance is succinic
`
`acid.
`
`22.
`
`(New) The analysis device according to claim 21, wherein the succinic acid is
`
`succinate at a concentration of at least 5 mg/ml.
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
